October 20, 2025

FDA Okays First Oral GLP-1 for CV Risk

Novo Nordisk’s once-daily GLP-1 tablet reduced major adverse cardiovascular events in high-risk adults, including those without prior heart attack or stroke.

Conexiant

October 14, 2025

Do Quadruple Therapies Beat Triple for H. pylori?

Concomitant and bismuth quadruple regimens cleared ~90% of patients and outperformed triple therapy; sequential achieved ~84%. Adherence remained ~97% despite higher but manageable side effects.

Conexiant

October 09, 2025

Medical Oddities: What Your Sleep Says About You

Five stories span sleep neuroscience, anti-aging dog training, a citrus misdiagnosis, green tea’s post-op benefits, and a gummy binge gone wrong.

Conexiant

October 07, 2025

Global IBD Trial Experts Agree on Steroid Standards

Global inflammatory bowel disease experts issued new guidance on how steroids should be managed in clinical trial settings.

Conexiant

September 29, 2025

Clinicians: Ultraprocessed Food Limits Coming to Cafeterias?

States consider bipartisan bans on ultraprocessed foods in schools over obesity and child health.

KFF Health News

September 26, 2025

Women's Depression Risk: The Soft Drink Link

Gut microbiome changes with soft drink intake in women with major depressive disorder.

Conexiant

September 26, 2025

Second-Surveillance Risk Hinges on Results of Prior Colonoscopies

Risk estimates are more accurate when clinicians consider serial findings rather than just the most recent exam.

Conexiant

September 24, 2025

Medical Oddities: Why Time on the Toilet Matters

From toilets to tea, bones to bullies, medicine’s strangest corners show us where science loves to surprise.

Conexiant

September 24, 2025

Prior TNF antagonist exposure influences efficacy of advanced therapies in ulcerative colitis

"Prior exposure to TNF antagonists appears to potentiate the efficacy of JAK inhibitors and IL-12/23 antagonists but may attenuate responsiveness to lymphocyte trafficking inhibitors."

Conexiant